Cargando…

The role of ATP1A3 gene in epilepsy: We need to know more

The ATP1A3 gene, which encodes the Na(+)/K(+)-ATPase α3 catalytic subunit, plays a crucial role in both physiological and pathological conditions in the brain, and mutations in this gene have been associated with a wide variety of neurological diseases by impacting the whole infant development stage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Shuang, Lan, Yu-Long, Gong, Yiwei, Chen, Zhong, Xu, Cenglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972585/ https://www.ncbi.nlm.nih.gov/pubmed/36866063 http://dx.doi.org/10.3389/fncel.2023.1143956

Ejemplares similares

Neurophysiology of the Developing Cerebral Cortex: What We Have Learned and What We Need to Know
por: Luhmann, Heiko J.
Publicado: (2022)

Identification of the prognostic and immunological roles of aquaporin 4: A potential target for survival and immunotherapy in glioma patients
por: Lan, Yu-Long, et al.
Publicado: (2022)

Ketogenic Diet and Epilepsy: What We Know So Far
por: D’Andrea Meira, Isabella, et al.
Publicado: (2019)

Neuroproteomics in Epilepsy: What Do We Know so Far?
por: do Canto, Amanda M., et al.
Publicado: (2021)

Carcinogenesis: The more we seek to know the more we need to know – Challenges in the post Genomic Era
por: Kovvali, Gopala, et al.
Publicado: (2003)

Plant virus metagenomics: what we know and why we need to know more
por: Stobbe, Anthony H., et al.
Publicado: (2014)

Ticks and Tularemia: Do We Know What We Don't Know?
por: Zellner, Briana, et al.
Publicado: (2019)

Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?
por: Boscia, Francesca, et al.
Publicado: (2021)

Commentary: We need to know more about erythropoietin
por: D'Ambra, Michael N.
Publicado: (2020)

For children left behind, we need to know more and do more
por: The Lancet Regional Health – Western Pacific
Publicado: (2023)

COVID-19—What we know and what we need to know: There are more questions than answers
por: Maisch, Bernhard, et al.
Publicado: (2020)

Circadian Rhythms in Bacterial Sepsis Pathology: What We Know and What We Should Know
por: Mul Fedele, Malena Lis, et al.
Publicado: (2021)

Hearing Loss and Cognition: What We Know and Where We Need to Go
por: Powell, Danielle S., et al.
Publicado: (2022)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Emerging Role of the Autophagy/Lysosomal Degradative Pathway in Neurodevelopmental Disorders With Epilepsy
por: Fassio, Anna, et al.
Publicado: (2020)

Connexin30-Deficiency Causes Mild Hearing Loss With the Reduction of Endocochlear Potential and ATP Release
por: Chen, Junmin, et al.
Publicado: (2022)

Contagious itch: what we know and what we would like to know
por: Schut, C., et al.
Publicado: (2015)

Homeostatic Plasticity in Epilepsy
por: Lignani, Gabriele, et al.
Publicado: (2020)

Micronutrients and the Immune System: Some Is Good but We Need to Know More
por: Thompson, Henry J.
Publicado: (2021)

Editorial: Epilepsy and Neurodevelopmental Diseases
por: Ruffolo, Gabriele, et al.
Publicado: (2020)

Big Tau: What We Know, and We Need to Know
por: Fischer, Itzhak
Publicado: (2023)

Protective Effects of Hydrogen Sulfide Against the ATP-Induced Meningeal Nociception
por: Koroleva, Kseniia, et al.
Publicado: (2020)

Inflammatory Cytokine Profile and Plasticity of Brain and Spinal Microglia in Response to ATP and Glutamate
por: Jesudasan, Sam Joshva Baskar, et al.
Publicado: (2021)

We Need to Know … Now!
por: Wojtys, Edward M.
Publicado: (2012)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Bacterial Vaginosis: What Do We Currently Know?
por: Abou Chacra, Linda, et al.
Publicado: (2022)

Transcriptional Regulation of Channelopathies in Genetic and Acquired Epilepsies
por: van Loo, Karen M. J., et al.
Publicado: (2020)

Histamine Intolerance—The More We Know the Less We Know. A Review
por: Hrubisko, Martin, et al.
Publicado: (2021)

Mechanisms Underlying Aquaporin-4 Subcellular Mislocalization in Epilepsy
por: Szu, Jenny I., et al.
Publicado: (2022)

Extracellular ATP-Induced Alterations in Extracellular H(+) Fluxes From Cultured Cortical and Hippocampal Astrocytes
por: Choi, Ji-in Vivien, et al.
Publicado: (2021)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Cryptococcus escapes host immunity: What do we know?
por: Yang, Chen, et al.
Publicado: (2022)

What do we know about the microbiome of I. ricinus?
por: Hodosi, Richard, et al.
Publicado: (2022)

GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020)

The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)

Nephrotoxicity testing in vitro--what we know and what we need to know.
por: Pfaller, W, et al.
Publicado: (1998)

Goal-directed therapy: what we know and what we need to know
por: O’Neal, Jason B, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s24js8j1jo3kvrcnsia76lsqra